ATE417830T1 - Sulfonylbenzimidazolderivate - Google Patents

Sulfonylbenzimidazolderivate

Info

Publication number: ATE417830T1
Authority: AT; Austria
Prior art keywords: sulfonylbenzimidazole; derivatives; sulfonylbenzimidazole derivatives
Prior art date: 2004-11-02

Application number

AT05800583T

Other languages

English (en)

Inventor

Kana Kon-I

Miyako Matsumizu

Akiko Shima

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-02

Filing date

2005-10-19

Publication date

2009-01-15

2005-10-19 Application filed by Pfizer filed Critical Pfizer

2009-01-15 Application granted granted Critical

2009-01-15 Publication of ATE417830T1 publication Critical patent/ATE417830T1/de

Links

IYUBCLHILARKQB-UHFFFAOYSA-N 2-sulfonylbenzimidazole Chemical class C1=CC=CC2=NC(=S(=O)=O)N=C21 IYUBCLHILARKQB-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT05800583T 2004-11-02 2005-10-19 Sulfonylbenzimidazolderivate ATE417830T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62457804P	2004-11-02	2004-11-02
US69635805P	2005-06-30	2005-06-30

Publications (1)

Publication Number	Publication Date
ATE417830T1 true ATE417830T1 (de)	2009-01-15

Family

ID=35915103

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05800583T ATE417830T1 (de)	2004-11-02	2005-10-19	Sulfonylbenzimidazolderivate

Country Status (18)

Country	Link
US (1)	US7598393B2 (de)
EP (1)	EP1809607B1 (de)
JP (1)	JP2008518905A (de)
AR (1)	AR053774A1 (de)
AT (1)	ATE417830T1 (de)
BR (1)	BRPI0517925A (de)
CA (1)	CA2586179C (de)
DE (1)	DE602005011844D1 (de)
DO (1)	DOP2005000221A (de)
ES (1)	ES2318556T3 (de)
GT (1)	GT200500309A (de)
MX (1)	MX2007005290A (de)
NL (1)	NL1030324C2 (de)
PA (1)	PA8651501A1 (de)
PE (1)	PE20060937A1 (de)
TW (1)	TW200621724A (de)
UY (1)	UY29184A1 (de)
WO (1)	WO2006048754A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL189872B1 (pl)	1996-07-24	2005-10-31	Warner Lambert Co	Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1797077B1 (de) *	2004-09-24	2012-02-15	AstraZeneca AB	Benzimidazolderivate, diese enthaltende zusammensetzungen, herstellung davon und anwendungen davon i
WO2007036718A2 (en) *	2005-09-30	2007-04-05	Glaxo Group Limited	Compounds which have activity at m1 receptor and their uses in medicine
US8283364B2 (en) *	2005-09-30	2012-10-09	Glaxo Group Limited	Compounds which have activity at M1 receptor and their uses in medicine
WO2007036711A1 (en) *	2005-09-30	2007-04-05	Glaxo Group Limited	BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
DE602007009807D1 (de)	2006-03-06	2010-11-25	Raqualia Pharma Inc	Sulfonylbenzimidazolderivate
TW200745049A (en)	2006-03-23	2007-12-16	Astrazeneca Ab	New crystalline forms
TW200808769A (en)	2006-04-18	2008-02-16	Astrazeneca Ab	Therapeutic compounds
ATE459352T1 (de) *	2006-07-04	2010-03-15	Janssen Pharmaceutica Nv	Benzimidazol-cannabinoid-agonisten mit einer substituierten heterocyclischen gruppe
WO2008085302A1 (en) *	2006-12-20	2008-07-17	Merck & Co., Inc.	Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
US8193369B2 (en)	2007-03-30	2012-06-05	Janssen Pharmaceutica Nv	Benzimidazole cannabinoid agonists
US8541476B2 (en) *	2007-09-14	2013-09-24	The Trustees Of The University Of Pennsylvania	Compounds for treatment of malignant tumors
GB0718415D0 (en) *	2007-09-20	2007-10-31	Glaxo Group Ltd	Compounds
JP5544299B2 (ja) *	2007-12-17	2014-07-09	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	フルオロアルキル置換ベンズイミダゾールカンナビノイドアゴニスト
CA2747801A1 (en)	2009-01-22	2010-07-29	Raqualia Pharma Inc.	N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
TWI546537B (zh) *	2009-05-19	2016-08-21	維維亞生技公司	提供針對血液腫瘤之體外個人化藥物測試之方法
US20110086853A1 (en) *	2009-10-08	2011-04-14	William Brown	Therapeutic Compounds
KR20120115252A (ko)	2009-11-06	2012-10-17	벤더르빌트 유니버시티	Ｍｇｌｕｒ4 알로스테릭 강화제로서 아릴 및 헤테로아릴 설폰, 조성물 및 신경 기능이상을 치료하는 방법
RU2414899C1 (ru) *	2009-12-29	2011-03-27	Аверин Константин Михайлович	Средства для лечения рассеянного склероза
CN105566182B (zh) *	2016-02-24	2018-02-13	苏州天马精细化学品股份有限公司	一种2‑氨基‑4‑（乙磺酰基）苯酚的合成方法
GB201811169D0 (en)	2018-07-06	2018-08-29	Kancera Ab	New compounds
US10569189B1 (en) *	2019-05-17	2020-02-25	NextLeaf Solutions Ltd.	Method for acetylation of cannabinoids
WO2022128050A1 (en)	2020-12-14	2022-06-23	Symrise Ag	Medicament for fighting inflammation and pain

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1481049A (fr) *	1965-11-25	1967-05-19	France Ministre Des Armees	Nouveaux dialkylaminoalkyl-1 p-alkoxyphényl alkyl-2 benzimidazoles 5-substitués
GB1198633A (en)	1967-11-24	1970-07-15	Ilford Ltd	Phenyl-Sulphonated Benzimidazoles
US4177057A (en) *	1977-10-25	1979-12-04	United States Borax & Chemical Corporation	Herbicidal benzimidazoles
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
DE19507913C2 (de) *	1995-03-07	1998-04-16	Agfa Gevaert Ag	Farbfotografisches Silberhalogenidmaterial
GB9518953D0 (en) *	1995-09-15	1995-11-15	Pfizer Ltd	Pharmaceutical formulations
WO1997024334A1 (en) *	1995-12-28	1997-07-10	Fujisawa Pharmaceutical Co., Ltd.	Benzimidazole derivatives
FR2751649B1 (fr) *	1996-07-26	1998-08-28	Adir	Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2000035296A1 (en)	1996-11-27	2000-06-22	Wm. Wrigley Jr. Company	Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
EP1060166A1 (de) *	1998-02-03	2000-12-20	Boehringer Ingelheim Pharma KG	5-gliedrige benzokondensierte heterocyclen als antithrombotika
WO2001016097A1 (en)	1999-08-27	2001-03-08	Sugen, Inc.	Phosphate mimics and methods of treatment using phosphatase inhibitors
EP1255750A1 (de)	2000-02-01	2002-11-13	Millenium Pharmaceuticals, Inc.	Indole und benzimidazole als factor xa inhibitoren
WO2002046168A1 (en)	2000-12-07	2002-06-13	Astrazeneca Ab	Therapeutic benzimidazole compounds
TW593278B (en)	2001-01-23	2004-06-21	Wyeth Corp	1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
CN1293072C (zh) *	2001-04-20	2007-01-03	惠氏公司	作为5－羟色胺－6配体的杂环基氧基－、－硫代－和－氨基吲哚衍生物
SE0101387D0 (sv) *	2001-04-20	2001-04-20	Astrazeneca Ab	Novel compounds
WO2002100833A1 (en) *	2001-06-12	2002-12-19	Sumitomo Pharmaceuticals Company, Limited	Rho KINASE INHIBITORS
SE0203070D0 (en) *	2002-10-16	2002-10-16	Astrazeneca Ab	Novel compounds
CN1816530A (zh)	2003-07-01	2006-08-09	麦克公司	用于治疗高眼压症的眼用组合物
SE0302571D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302573D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv)	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) *	2003-09-26	2003-09-26	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CA2582347C (en) *	2004-09-30	2014-09-23	Janssen Pharmaceutica N.V.	Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
EP1805147B1 (de) *	2004-09-30	2014-08-13	Janssen Pharmaceutica NV	Als selektive androgenrezeptormodulatoren (sarms) geeignete, neue benzimidazolderivate

2005
- 2005-10-19 ES ES05800583T patent/ES2318556T3/es not_active Expired - Lifetime
- 2005-10-19 CA CA2586179A patent/CA2586179C/en not_active Expired - Fee Related
- 2005-10-19 WO PCT/IB2005/003325 patent/WO2006048754A1/en not_active Ceased
- 2005-10-19 AT AT05800583T patent/ATE417830T1/de not_active IP Right Cessation
- 2005-10-19 BR BRPI0517925-4A patent/BRPI0517925A/pt not_active IP Right Cessation
- 2005-10-19 EP EP05800583A patent/EP1809607B1/de not_active Expired - Lifetime
- 2005-10-19 JP JP2007538543A patent/JP2008518905A/ja active Pending
- 2005-10-19 MX MX2007005290A patent/MX2007005290A/es active IP Right Grant
- 2005-10-19 DE DE602005011844T patent/DE602005011844D1/de not_active Expired - Lifetime
- 2005-10-27 DO DO2005000221A patent/DOP2005000221A/es unknown
- 2005-10-28 PE PE2005001266A patent/PE20060937A1/es not_active Application Discontinuation
- 2005-10-28 GT GT200500309A patent/GT200500309A/es unknown
- 2005-10-31 UY UY29184A patent/UY29184A1/es not_active Application Discontinuation
- 2005-11-01 AR ARP050104571A patent/AR053774A1/es unknown
- 2005-11-01 NL NL1030324A patent/NL1030324C2/nl not_active IP Right Cessation
- 2005-11-01 TW TW094138221A patent/TW200621724A/zh unknown
- 2005-11-02 US US11/266,107 patent/US7598393B2/en not_active Expired - Fee Related
- 2005-11-02 PA PA20058651501A patent/PA8651501A1/es unknown

Also Published As

Publication number	Publication date
UY29184A1 (es)	2006-06-30
PE20060937A1 (es)	2006-10-19
MX2007005290A (es)	2007-07-09
AR053774A1 (es)	2007-05-23
DOP2005000221A (es)	2006-05-15
US7598393B2 (en)	2009-10-06
CA2586179C (en)	2011-02-08
PA8651501A1 (es)	2006-06-02
CA2586179A1 (en)	2006-05-11
DE602005011844D1 (de)	2009-01-29
US20060094750A1 (en)	2006-05-04
WO2006048754A1 (en)	2006-05-11
EP1809607B1 (de)	2008-12-17
EP1809607A1 (de)	2007-07-25
ES2318556T3 (es)	2009-05-01
TW200621724A (en)	2006-07-01
GT200500309A (es)	2006-09-11
BRPI0517925A (pt)	2008-10-21
NL1030324C2 (nl)	2006-11-27
NL1030324A1 (nl)	2006-05-03
JP2008518905A (ja)	2008-06-05

Legal Events

Date	Code	Title	Description
2009-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
IS8578A (is)	2006-12-08	3- karbamoýl - 2- pýridón afleiður
DK1725553T3 (da)	2008-08-18	Tetrahydropyridoindolderivater
ATE540935T1 (de)	2012-01-15	Chinazolinderivate
EP1756259A4 (de)	2009-09-23	Rührkesselreaktorsystem
DE602005026015D1 (de)	2011-03-03	Antiadhäsionssperrschicht
DK1761541T3 (da)	2008-04-28	Pyrrazolo-pyrimidin-derivater
DE502005005628D1 (de)	2008-11-20	Wischblatt
ATE553079T1 (de)	2012-04-15	Heteroarylphenylharnstoffderivat
DE602005013397D1 (de)	2009-04-30	Radom-struktur
ATE417830T1 (de)	2009-01-15	Sulfonylbenzimidazolderivate
ATE392425T1 (de)	2008-05-15	Thiazolyl-dihydro-indazole
DE602005023008D1 (de)	2010-09-30	Zugbetriebssteuersystem
DE602005007966D1 (de)	2008-08-21	Reifenabdrückvorrichtung
DE502005004842D1 (de)	2008-09-04	Wischblatt
DE602006010581D1 (de)	2009-12-31	4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de)	2010-11-15	Azaindol-2-carboxamid-derivate
DE112005000809A5 (de)	2007-05-24	Wankstabilisierungseinrichtung
DE602005026084D1 (de)	2011-03-10	Tintenstrahlkopfanornung
ATE430142T1 (de)	2009-05-15	Phenylpiperazin-methanon-derivate
DE602005002296D1 (de)	2007-10-18	Buschschneider
ATE527255T1 (de)	2011-10-15	Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da)	2012-10-22	Tiglien-3-onderivater
ATE404542T1 (de)	2008-08-15	4-phenylpyrimidin-2-carbonitrilderivate
DE602005006886D1 (de)	2008-07-03	Gaschromatographmassenspektrometer
DK1740574T3 (da)	2007-10-15	4-amino-5-cyanopyrimidinderivater